Skip to main content
logo
Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
1.000
+0.020 (2.04%)
At close: Jan 9, 2026

Vaccinex Revenue

In the year 2024, Vaccinex had annual revenue of $601.00K with 5.44% growth. Vaccinex had revenue of $213.00K in the quarter ending December 31, 2024.

Revenue
601.00K
Revenue Growth
+5.44%
P/S Ratio
4.45
Revenue / Employee
24.04K
Employees
27
Market Cap
2.68M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024601.00K31.00K5.44%
Dec 31, 2023570.00K295.00K107.27%
Dec 31, 2022275.00K-625.00K-69.44%
Dec 31, 2021900.00K275.00K44.00%
Dec 31, 2020625.00K102.00K19.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Glass House Brands196.17M
Vaxart148.20M
Elite Pharmaceuticals122.89M
Zomedica29.45M
Silence Therapeutics25.83M
OpGen9.00M
Revenue Rankings

Vaccinex News

More News